Spire Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$62.8K | – | 2494 |
|
|
2023
Q1 | $62.8K | Hold |
1,000
| – | – | ﹤0.01% | 1104 |
|
|
2022
Q4 | $63K | Hold |
1,000
| – | – | ﹤0.01% | 910 |
|
|
2022
Q3 | $59K | Hold |
1,000
| – | – | ﹤0.01% | 894 |
|
|
2022
Q2 | $58K | Hold |
1,000
| – | – | ﹤0.01% | 1235 |
|
|
2022
Q1 | $62K | Hold |
1,000
| – | – | ﹤0.01% | 1363 |
|
|
2021
Q4 | $71K | Hold |
1,000
| – | – | ﹤0.01% | 1556 |
|
|
2021
Q3 | $75K | Hold |
1,000
| – | – | ﹤0.01% | 1309 |
|
|
2021
Q2 | $77K | Hold |
1,000
| – | – | ﹤0.01% | 1305 |
|
|
2021
Q1 | $74K | Buy |
+1,000
| New | +$74K | ﹤0.01% | 1532 |
|